Skip to content

Clinical trials

Phase 4 Diabetic Neuropathies trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Neuropathies Phase: Phase 4 Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20043
20054
20067
20071
20081
20093
20103
20121
20132
20141
20153
20161
20181
20191
20201
20212
20221
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34
Terminated3
Unknown status3
Not yet recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.4
Eli Lilly and Company3
Eastern Virginia Medical School2
Endo USA Inc., a Keenova Therapeutics Company2
Wake Forest University2
Ain Shams University1
Alexandria University1
Analgesic Solutions1
Aristotle University Of Thessaloniki1
Boehringer Ingelheim1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Neuropathies43
Diabetes Mellitus5
Neuralgia, Postherpetic5
Diabetes Mellitus, Type 24
Neuralgia4
Peripheral Nervous System Diseases3
Low Back Pain2
Bronchiolitis Obliterans Syndrome1
Carpal Tunnel Syndrome1
Complex Regional Pain Syndromes1

Trials

Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.